Inflammation Inhibitor Fails to Affect CV Outcomes

(MedPage Today) -- A novel agent that targets the inflammation process failed to reduce heart attack, stroke, or cardiovascular death in at-risk individuals when compared with placebo, researchers reported here.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news